A Prospective, Randomized, Double-Blind Clinical Trial Evaluating the Speed of Recovery and Safety of Reversal of Neuromuscular Blockade With Sugammadex (Bridion™) Versus Neostigmine in Geriatric Patients Undergoing Spine Surgery
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 15 Aug 2018 Status changed from recruiting to completed.
- 16 May 2018 Planned End Date changed from 1 May 2018 to 1 Dec 2018.
- 16 May 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Oct 2018.